VCG
Vantage Consulting Group’s FibroGen FGEN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-195,707
| Closed | -$60.7K | – | 4 |
|
|
2025
Q1 | $60.7K | Hold |
195,707
| – | – | 1.21% | 4 |
|
|
2024
Q4 | $104K | Hold |
195,707
| – | – | 0.99% | 5 |
|
|
2024
Q3 | $78.2K | Hold |
195,707
| – | – | 0.68% | 4 |
|
|
2024
Q2 | $175K | Hold |
195,707
| – | – | 0.13% | 184 |
|
|
2024
Q1 | $460K | Hold |
195,707
| – | – | 0.29% | 36 |
|
|
2023
Q4 | $173K | Hold |
195,707
| – | – | 0.12% | 197 |
|
|
2023
Q3 | $169K | Hold |
195,707
| – | – | 0.11% | 195 |
|
|
2023
Q2 | $528K | Sell |
195,707
-96,000
| -33% | -$259K | 0.3% | 20 |
|
|
2023
Q1 | $5.44M | Sell |
291,707
-314,006
| -52% | -$5.86M | 3.09% | 4 |
|
|
2022
Q4 | $9.7M | Hold |
605,713
| – | – | 5.73% | 3 |
|
|
2022
Q3 | $7.88M | Hold |
605,713
| – | – | 4.6% | 3 |
|
|
2022
Q2 | $6.4M | Buy |
605,713
+540
| +0.1% | +$5.7K | 3.59% | 4 |
|
|
2022
Q1 | $7.28M | Sell |
605,173
-540
| -0.1% | -$6.5K | 2.84% | 4 |
|
|
2021
Q4 | $8.54M | Hold |
605,713
| – | – | 2.3% | 5 |
|
|
2021
Q3 | $6.19M | Hold |
605,713
| – | – | 1.33% | 5 |
|
|
2021
Q2 | $16.1M | Hold |
605,713
| – | – | 2.81% | 4 |
|
|
2021
Q1 | $21M | Hold |
605,713
| – | – | 4.22% | 3 |
|
|
2020
Q4 | $22.5M | Buy |
+605,713
| New | +$22.5M | 1.83% | 3 |
|